Clostridium acetobutylicum ATCC 824

Clostridium acetobutylicum ATCC 824 is a gram-positive, rod-shaped bacterium that thrives in a thermophilic environment, falling under the category of " Mesophilic" temperature preference. As a chemoheterotroph, it relies on organic compounds as its energy source, where it uses fermentation as its mode of energy production. This means that C. acetobutylicum ATCC 824 does not require light for energy, and instead, breaks down organic molecules to produce ATP. The bacterium's gram-positive staining characteristics indicate the presence of a thick peptidoglycan cell wall, which provides structural support and protection against external environmental factors. Its rod-shaped morphology allows it to adapt to various environments and interact with its surroundings effectively. C. acetobutylicum ATCC 824 is an obligate anaerobe, meaning that it cannot thrive in the presence of oxygen and is susceptible to damage or even death from exposure to atmospheric oxygen. This adaptation enables it to survive in environments where oxygen levels are low or absent, such as soil, sediments, and the human gastrointestinal tract. In terms of body sites, C. acetobutylicum ATCC 824 can be found in various parts of the human body, including the gut, skin, and reproductive tract. It is also commonly isolated from soil, sewage, and industrial environments. One of the most notable features of C. acetobutylicum ATCC 824 is its ability to produce a wide range of bioactive compounds, including acetone, butanol, and ethanol, which are produced during fermentation. This microbe has been extensively studied in the context of industrial biofuel production, biotechnology, and bioremediation. Furthermore, C. acetobutylicum ATCC 824 has been found to possess genes involved in the biosynthesis of antimicrobial compounds, such as antimicrobial peptides and bacteriocins. These compounds have been shown to exhibit potent antimicrobial activity against other microorganisms, making this microbe a valuable subject for further research into antimicrobial resistance and the development of novel antibiotics.